OrphAI Therapeutics
Pre-clinicalAt OrphAI Therapeutics, we are focused on identifying and developing new and innovative treatments for disease. Our current clinical stage drug candidates target several disorders including pulmonary hypertension (PH), Bronchiolitis Obliterans Syndrome (BOS) post lung transplant, and oncology indications.
Founded
2020
Focus
AI / Machine LearningSmall Molecules
About
At OrphAI Therapeutics, we are focused on identifying and developing new and innovative treatments for disease. Our current clinical stage drug candidates target several disorders including pulmonary hypertension (PH), Bronchiolitis Obliterans Syndrome (BOS) post lung transplant, and oncology indications.
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile